Dosilicon Selling General Administrative vs Research Development Analysis

688110 Stock

24.76 0.05 0.20%

Dosilicon financial indicator trend analysis is much more than just examining Dosilicon latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dosilicon is a good investment. Please check the relationship between Dosilicon Selling General Administrative and its Research Development accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Dosilicon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative vs Research Development

Selling General Administrative vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dosilicon Selling General Administrative account and Research Development. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Dosilicon's Selling General Administrative and Research Development is -0.19. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Research Development in the same time period over historical financial statements of Dosilicon Co, assuming nothing else is changed. The correlation between historical values of Dosilicon's Selling General Administrative and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Dosilicon Co are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling General Administrative i.e., Dosilicon's Selling General Administrative and Research Development go up and down completely randomly.

Correlation Coefficient

-0.19

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Selling General Administrative

Research Development

Most indicators from Dosilicon's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dosilicon current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Dosilicon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of January 6, 2025, Selling General Administrative is expected to decline to about 15.5 M. The current year's Tax Provision is expected to grow to about (43.7 M)

	2022	2024	2025 (projected)
Interest Expense	2.2M	2.9M	3.9M
Depreciation And Amortization	33.0M	37.9M	30.6M

Interest Expense Depreciation And Amortization

Dosilicon fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Net Receivables	Net Invested Capital
Total Assets		-0.59	-0.48	-0.21	0.95	0.89	-0.96	0.68	0.17	0.95	0.78	0.77	0.95	0.9	-0.85	0.87	0.36	0.94	-0.46	0.99	-0.21	-0.66	0.94	-0.88	-0.15	0.99
Short Long Term Debt Total	-0.59		0.24	0.69	-0.61	-0.57	0.64	-0.53	0.23	-0.62	-0.43	-0.41	-0.63	-0.52	0.73	-0.43	0.08	-0.59	0.81	-0.61	0.87	0.65	-0.63	0.77	0.13	-0.59
Other Current Liab	-0.48	0.24		0.61	-0.59	-0.75	0.41	0.11	0.46	-0.25	-0.84	-0.83	-0.51	-0.72	0.51	-0.8	-0.68	-0.61	0.67	-0.39	0.0	0.67	-0.63	0.6	0.8	-0.49
Total Current Liabilities	-0.21	0.69	0.61		-0.29	-0.43	0.19	0.12	0.75	-0.06	-0.45	-0.44	-0.24	-0.44	0.43	-0.42	-0.18	-0.3	0.95	-0.16	0.67	0.58	-0.38	0.51	0.67	-0.21
Total Stockholder Equity	0.95	-0.61	-0.59	-0.29		0.96	-0.97	0.6	0.1	0.91	0.87	0.87	0.99	0.87	-0.85	0.83	0.49	1.0	-0.52	0.95	-0.26	-0.68	0.91	-0.92	-0.19	0.97
Property Plant And Equipment Net	0.89	-0.57	-0.75	-0.43	0.96		-0.87	0.45	-0.11	0.77	0.97	0.96	0.92	0.93	-0.84	0.89	0.63	0.97	-0.63	0.84	-0.21	-0.69	0.88	-0.92	-0.44	0.91
Net Debt	-0.96	0.64	0.41	0.19	-0.97	-0.87		-0.69	-0.21	-0.97	-0.74	-0.73	-0.98	-0.8	0.85	-0.76	-0.33	-0.96	0.44	-0.98	0.3	0.64	-0.9	0.89	0.02	-0.97
Retained Earnings	0.68	-0.53	0.11	0.12	0.6	0.45	-0.69		0.61	0.8	0.24	0.25	0.6	0.4	-0.56	0.38	-0.27	0.54	-0.09	0.74	-0.34	-0.46	0.6	-0.57	0.37	0.66
Accounts Payable	0.17	0.23	0.46	0.75	0.1	-0.11	-0.21	0.61		0.35	-0.25	-0.23	0.13	-0.19	0.16	-0.11	-0.37	0.05	0.66	0.26	0.2	0.09	0.05	0.14	0.8	0.15
Cash	0.95	-0.62	-0.25	-0.06	0.91	0.77	-0.97	0.8	0.35		0.61	0.6	0.94	0.73	-0.81	0.69	0.17	0.89	-0.33	0.98	-0.29	-0.59	0.87	-0.83	0.13	0.95
Non Current Assets Total	0.78	-0.43	-0.84	-0.45	0.87	0.97	-0.74	0.24	-0.25	0.61		1.0	0.81	0.91	-0.73	0.87	0.79	0.9	-0.61	0.71	-0.09	-0.58	0.77	-0.81	-0.59	0.81
Non Currrent Assets Other	0.77	-0.41	-0.83	-0.44	0.87	0.96	-0.73	0.25	-0.23	0.6	1.0		0.8	0.91	-0.72	0.87	0.79	0.89	-0.6	0.7	-0.07	-0.57	0.76	-0.81	-0.59	0.81
Cash And Short Term Investments	0.95	-0.63	-0.51	-0.24	0.99	0.92	-0.98	0.6	0.13	0.94	0.81	0.8		0.82	-0.85	0.78	0.44	0.99	-0.49	0.95	-0.29	-0.64	0.9	-0.9	-0.1	0.97
Common Stock Shares Outstanding	0.9	-0.52	-0.72	-0.44	0.87	0.93	-0.8	0.4	-0.19	0.73	0.91	0.91	0.82		-0.83	0.96	0.6	0.88	-0.63	0.83	-0.12	-0.64	0.88	-0.86	-0.55	0.9
Non Current Liabilities Total	-0.85	0.73	0.51	0.43	-0.85	-0.84	0.85	-0.56	0.16	-0.81	-0.73	-0.72	-0.85	-0.83		-0.75	-0.3	-0.84	0.68	-0.84	0.3	0.76	-0.88	0.97	0.34	-0.85
Inventory	0.87	-0.43	-0.8	-0.42	0.83	0.89	-0.76	0.38	-0.11	0.69	0.87	0.87	0.78	0.96	-0.75		0.53	0.84	-0.6	0.8	-0.07	-0.74	0.91	-0.8	-0.55	0.85
Other Current Assets	0.36	0.08	-0.68	-0.18	0.49	0.63	-0.33	-0.27	-0.37	0.17	0.79	0.79	0.44	0.6	-0.3	0.53		0.54	-0.25	0.27	0.32	-0.03	0.29	-0.35	-0.59	0.43
Other Stockholder Equity	0.94	-0.59	-0.61	-0.3	1.0	0.97	-0.96	0.54	0.05	0.89	0.9	0.89	0.99	0.88	-0.84	0.84	0.54		-0.53	0.93	-0.24	-0.66	0.9	-0.91	-0.23	0.97
Total Liab	-0.46	0.81	0.67	0.95	-0.52	-0.63	0.44	-0.09	0.66	-0.33	-0.61	-0.6	-0.49	-0.63	0.68	-0.6	-0.25	-0.53		-0.41	0.64	0.72	-0.61	0.74	0.66	-0.46
Total Current Assets	0.99	-0.61	-0.39	-0.16	0.95	0.84	-0.98	0.74	0.26	0.98	0.71	0.7	0.95	0.83	-0.84	0.8	0.27	0.93	-0.41		-0.26	-0.66	0.93	-0.87	-0.02	0.98
Short Term Debt	-0.21	0.87	0.0	0.67	-0.26	-0.21	0.3	-0.34	0.2	-0.29	-0.09	-0.07	-0.29	-0.12	0.3	-0.07	0.32	-0.24	0.64	-0.26		0.39	-0.27	0.39	-0.07	-0.22
Intangible Assets	-0.66	0.65	0.67	0.58	-0.68	-0.69	0.64	-0.46	0.09	-0.59	-0.58	-0.57	-0.64	-0.64	0.76	-0.74	-0.03	-0.66	0.72	-0.66	0.39		-0.86	0.81	0.36	-0.62
Common Stock	0.94	-0.63	-0.63	-0.38	0.91	0.88	-0.9	0.6	0.05	0.87	0.77	0.76	0.9	0.88	-0.88	0.91	0.29	0.9	-0.61	0.93	-0.27	-0.86		-0.91	-0.28	0.92
Long Term Debt	-0.88	0.77	0.6	0.51	-0.92	-0.92	0.89	-0.57	0.14	-0.83	-0.81	-0.81	-0.9	-0.86	0.97	-0.8	-0.35	-0.91	0.74	-0.87	0.39	0.81	-0.91		0.35	-0.88
Net Receivables	-0.15	0.13	0.8	0.67	-0.19	-0.44	0.02	0.37	0.8	0.13	-0.59	-0.59	-0.1	-0.55	0.34	-0.55	-0.59	-0.23	0.66	-0.02	-0.07	0.36	-0.28	0.35		-0.15
Net Invested Capital	0.99	-0.59	-0.49	-0.21	0.97	0.91	-0.97	0.66	0.15	0.95	0.81	0.81	0.97	0.9	-0.85	0.85	0.43	0.97	-0.46	0.98	-0.22	-0.62	0.92	-0.88	-0.15

Click cells to compare fundamentals

Dosilicon Account Relationship Matchups

Dosilicon fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	758.8M	4.2B	4.3B	3.8B	4.4B	2.3B
Short Long Term Debt Total	83.3M	37.5M	43.6M	69.5M	62.6M	63.0M
Other Current Liab	33.1M	64.7M	34.2M	334.7K	301.2K	286.1K
Total Current Liabilities	99.6M	189.8M	184.1M	131.9M	118.7M	130.3M
Total Stockholder Equity	501.4M	3.8B	3.9B	3.5B	4.0B	4.2B
Property Plant And Equipment Net	41.1M	78.2M	141.6M	136.7M	157.2M	165.0M
Net Debt	34.6M	(263.3M)	(3.4B)	(2.5B)	(2.2B)	(2.1B)
Retained Earnings	(91.8M)	152.4M	232.5M	(129.7M)	(149.1M)	(141.7M)
Accounts Payable	40.7M	95.9M	90.5M	52.6M	47.3M	57.7M
Cash	300.8M	3.4B	2.5B	1.7B	1.9B	1.3B
Non Current Assets Total	57.1M	117.7M	810.6M	972.7M	1.1B	1.2B
Non Currrent Assets Other	7.0M	28.6M	650.5M	722.5M	830.8M	872.4M
Cash And Short Term Investments	48.7M	300.8M	3.4B	2.5B	2.9B	3.1B
Liabilities And Stockholders Equity	705.6M	758.8M	4.2B	4.3B	5.0B	5.2B
Non Current Liabilities Total	21.8M	23.3M	22.7M	22.1M	19.8M	27.2M
Inventory	295.4M	349.0M	668.2M	756.5M	870.0M	470.9M
Other Current Assets	4.5M	17.0M	118.5M	201.4M	231.7M	243.2M
Other Stockholder Equity	198.7M	261.5M	3.2B	3.3B	3.7B	3.9B
Total Liab	121.4M	213.1M	206.9M	154.0M	138.6M	157.5M
Total Current Assets	701.7M	4.1B	3.5B	2.9B	3.3B	2.0B
Short Term Debt	35.7M	25.8M	29.2M	59.4M	53.5M	42.5M
Intangible Assets	936.6K	4.0M	3.6M	3.0M	2.7M	3.3M
Common Stock	280.7M	316.5M	331.7M	442.2M	508.6M	369.1M
Net Receivables	89.5M	254.9M	138.4M	65.1M	58.6M	111.2M
Net Invested Capital	538.9M	3.9B	4.0B	3.5B	4.1B	2.7B
Short Long Term Debt	25.8M	29.2M	59.4M	43.0M	49.4M	42.5M
Net Working Capital	602.0M	3.9B	3.3B	2.7B	3.2B	2.4B

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

Other Information on Investing in Dosilicon Stock

Balance Sheet is a snapshot of the financial position of Dosilicon at a specified time, usually calculated after every quarter, six months, or one year. Dosilicon Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dosilicon and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Dosilicon currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dosilicon Selling General Administrative vs Research Development Analysis

Selling General Administrative vs Research Development

Selling General Administrative vs Research Development Correlation Analysis

Correlation Coefficient

Selling General Administrative

Research Development

Dosilicon fundamental ratios Correlations

Dosilicon Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dosilicon fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Dosilicon Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Non Currrent Assets Other	+ 1.0	Non Current Assets Total
Total Current Assets	+ 0.99	Total Assets
Net Invested Capital	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Other Stockholder Equity	+ 0.99	Cash And Short Term Investments

Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Net Invested Capital	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.97	Total Stockholder Equity
Other Stockholder Equity	- 0.96	Net Debt